| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.00069 | 1 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.00095 | 1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.00063 | 1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.00051 | 1 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.0025 | 1 |